Release Date: February 27, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Q: Can you provide any color on expectations for defense and commercial markets, specifically regarding the MAX program and potential destocking risks in early 2025? A: Stephen Oswald, CEO: We anticipate destocking headwinds in the first half of 2025, particularly with Spirit. However, we expect improvements in the second half as build rates increase. Defense markets remain strong, supported by a solid backlog and new orders, such as the recent $40 million order from Bayern-Chemie.
Q: What percentage of your defense sales end up in Europe, and how will you benefit from increased defense spending there? A: Stephen Oswald, CEO: The recent $40 million order from Bayern-Chemie is one of our first direct shipments to Europe. While we benefit from European defense spending through U.S. defense primes, this direct order is a new development, and we hope for more in the future.
Q: How does Ducommun position itself amid potential defense budget cuts under the new administration? A: Suman Mookerji, CFO: We are diversified across multiple programs, with no single program accounting for more than 10% of our defense revenues. Our focus on strategic areas like missile defense and electronic warfare should help offset any potential cuts to legacy platforms.
Q: With the potential slowdown in the ViaSat business, how are you planning for capacity transitions? A: Stephen Oswald, CEO: We are well-positioned with high demand for our Appleton products, including next-generation Jammer. We may seek additional space in the next year or two, despite the expected decline in ViaSat work.
Q: Can you provide more details on the legal fees related to the unsolicited acquisition offer? A: Suman Mookerji, CFO: The legal fees were necessary to protect shareholder interests in response to an unsolicited offer from Albion River. These expenses are not expected to continue in 2025, as Albion has sold its position in Ducommun.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
This article first appeared on GuruFocus.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.